Related Experiment Video
Updated: Apr 20, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular disease prevalence and relevance in haemophilia: a scoping review
I Rizwan1, L Minuk2, S Jackson3
1Clinical Epidemiology and Biostatistics, McMaster University, Hamilton.
Insights
Cardiovascular disease (CVD) risk in patients with haemophilia is rising with increased longevity. However, research is conflicting on whether haemophilia protects against CVD or if aging PWH experience more events.
Area of Science:
- Hematology
- Cardiology
- Public Health
Background:
- Patients with haemophilia (PWH) are living longer due to improved treatments.
- Increased longevity in PWH raises concerns about age-related cardiovascular disease (CVD) risk.
- The shift in comorbidities necessitates evaluating the care model for aging PWH.
Purpose of the Study:
- To assess the robustness of publications on CVD and haemophilia.
- To determine if PWH longevity and associated CVD risk factors lead to CVD events.
- To evaluate the need for expanded care for aging PWH.
Main Methods:
- A scoping review was conducted.
- 30 articles were selected and organized by publication date.
- A citation matrix identified primary research articles on CVD risk factors in PWH.
Main Results:
- Four of 14 original articles suggested a protective effect of haemophilia against CVD.
- Twelve articles found similar CVD prevalence in PWH compared to the general population.
- Seven articles reported a different CVD prevalence in the aging haemophilia population, indicating conflicting evidence.
Conclusions:
- Existing literature provides conflicting evidence on whether haemophilia confers a protective effect against CVD.
- The scoping review could not definitively conclude if PWH longevity and associated CVD risk factors lead to CVD events due to inconsistent findings in the assessed articles.
Abstract:
The prevalence of cardiovascular disease (CVD) risk and events in patients with haemophilia (PWH) is expected to increase as the longevity of this cohort increases due to treatment advances since the 1950s. The aims of this study were to assess publications of CVD and haemophilia for robustness, determine if the increasing longevity of PWH and associated age-related CVD risk factors result in CVD events; assess the need for an extension of the circle of care for ageing PWH due to the shift in comorbidities. A scoping review was conducted, resulting in a final pool of 30 articles which were organized based on publication dates. A matrix was created to illustrate which articles cited articles published prior to its own publication. This led to the identification of the primary articles, receiving the highest number of citations by other publications, which drive the research pertaining to the study of age-related risk factors of CVD in PWH. The scoping review revealed 14 original articles, four of which indicated a protective effect of haemophilia toward CVD. Twelve articles demonstrated a similar prevalence of CVD in PWH compared to the general population while seven articles concluded a difference in the prevalence of CVD in the ageing haemophilia population. The existing literature presented conflicting evidence regarding the possibility of a protective effect of haemophilia against CVD. The scoping review was not able to finalize whether the longevity of PWH and their associated age-related CVD risk factors result in CVD events because the articles assessed reported conflicting results.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

